Artificial Intelligence

The acquisition creates an end-to-end intelligence platform, combining institutional AI with alternative data to challenge generic models in finance.

A partnership between NSA Labs and Proscia is slashing study times for brain research, showing how digital platforms are key to finding new therapies faster.

As creators face relentless pressure, RHEI's Made platform launches AI agents to automate video production and protect IP, reshaping the creator economy.

With its new SOC 2 Type 2 certification, Tech Foundry aims to set a new standard for secure, high-touch software development for SaaS enterprises.

Sifted's new agentic AI platform acts as an 'always-on analyst,' promising to slash shipping costs and complexity by making autonomous, data-driven moves.

In a strategic move to restore trust in digital health, HealthCentral has acquired an AI platform that vets and activates physician influencers.

Annexon Biosciences spotlights its novel C1q inhibitor, Vonaprument, aiming to be the first therapy to preserve vision in geographic atrophy patients.

Partnering with Riskified, the travel platform boosted approvals to 93%, enabling expansion and enhancing customer experience in a high-fraud region.

Facing a tech shortage & vehicle complexity, Autoshop Answers launches a national virtual training series to arm repair shops with critical new skills.

Partnering with Stripe's Bridge, Payoneer is embedding stablecoin payments to simplify cross-border trade for its nearly 2 million business customers.

LiveRamp adds Uber's ad chief and retail media architect Kristi Argyilan to its board, signaling a major push into the future of AI-driven commerce media.

A new oral drug from Nimbus Therapeutics uses AI-driven precision to fight inflammation and repair tissue, offering new hope for millions with IBD.

The toy giant unveils its 2026 lineup, blending high-tech pets with purposeful play and making a bold, strategic move into the lucrative adult gaming market.

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

Israeli tech firm Nanox will debut its low-cost Nanox.ARC imaging system in Europe, pairing it with AI that spots chronic disease in routine scans.

An independent board again backs the safety of BriaCell's metastatic breast cancer therapy in a pivotal Phase 3 trial, boosting hope for a new treatment.

Continu launches 'Experts,' an AI tool that securely connects to Google Drive and OneDrive, delivering instant, permission-aware answers in Slack and Teams.

New research reveals a startling link between AI's excessive permissions and a surge in security breaches, forcing a rethink of enterprise trust and access.

New research reveals a startling mobile security gap, with 72% of firms facing incidents and 65% losing customers as AI and speed pressures add new risks.